Siregar Adiatma Ym, Pitriyan Pipit, Wisaksana Rudi
Department of Economics, Center for Economics and Development Studies, Faculty of Economics and Business, Padjadjaran University, Bandung, Indonesia.
Acta Med Indones. 2016 Jul;48(3):207-216.
this study reported various factors associated with a higher probability of HIV patients drop out, and potential productivity loss due to HIV patients drop out.
we analyzed data of 658 HIV patients from a database in a main referral hospital in Bandung city, West Java, Indonesia from 2007 to 2013. First, we utilized probit regression analysis and included, among others, the following variables: patients' status (active or drop out), CD4 cell count, TB and opportunistic infection (OI), work status, sex, history of injecting drugs, and support from family and peers. Second, we used the drop out data from our database and CD 4 cell count decline rate from another study to estimate the productivity loss due to HIV patients drop out.
lower CD4 cell count was associated with a higher probability of drop out. Support from family/peers, living with family, and diagnosed with TB were associated with lower probability of drop out. The productivity loss at national level due to treatment drop out (consequently, due to CD4 cell count decline) can reach US$365 million (using average wage).
first, as lower CD 4 cell count was associated with higher probability of drop out, we recommend (to optimize) early ARV initiation at a higher CD 4 cell count, involving scaling up HIV service at the community level. Second, family/peer support should be further emphasized to further ensure treatment success. Third, dropping out from ART will result in a relatively large productivity loss.
本研究报告了与艾滋病病毒(HIV)患者更高脱落概率相关的各种因素,以及因HIV患者脱落导致的潜在生产力损失。
我们分析了来自印度尼西亚西爪哇省万隆市一家主要转诊医院数据库中2007年至2013年期间658例HIV患者的数据。首先,我们采用了概率单位回归分析,并纳入了以下变量:患者状态(活跃或脱落)、CD4细胞计数、结核病和机会性感染(OI)、工作状态、性别、注射吸毒史以及来自家庭和同伴的支持。其次,我们使用数据库中的脱落数据和另一项研究中的CD4细胞计数下降率来估计因HIV患者脱落导致的生产力损失。
较低的CD4细胞计数与更高的脱落概率相关。来自家庭/同伴的支持、与家人同住以及被诊断患有结核病与较低的脱落概率相关。由于治疗中断(进而由于CD4细胞计数下降)在国家层面导致的生产力损失可达3.65亿美元(使用平均工资)。
第一,由于较低的CD4细胞计数与更高的脱落概率相关,我们建议在更高的CD4细胞计数时(优化)尽早开始抗逆转录病毒治疗,包括在社区层面扩大HIV服务。第二,应进一步强调家庭/同伴支持以进一步确保治疗成功。第三,停止抗逆转录病毒治疗将导致相对较大的生产力损失。